Curcumin, Berberine Emerge as Top Fibrosarcoma Candidates in 5-Compound Lab Study
Updated
Updated · studyfinds.com · Jul 27
Curcumin, Berberine Emerge as Top Fibrosarcoma Candidates in 5-Compound Lab Study
3 articles · Updated · studyfinds.com · Jul 27
Summary
Five plant compounds tested against mouse Fibrosarcoma cells left curcumin and berberine as the strongest balance of anticancer activity and early safety, while Biochanin A collapsed in follow-up toxicity screening.
Berberine drained about 92% of tumor-cell energy stores, and curcumin pushed more than 75% of fibrosarcoma cells into a senescence-linked state, with both generally hitting cancer cells harder than normal muscle cells.
Biochanin A looked potent in cell culture but proved the riskiest in wax moth larvae, with only 2 of 10 surviving past day one; Cucurbitacin E also showed higher toxicity than curcumin or berberine.
Larval survival stayed near control levels for the leading candidates—9 of 10 for berberine through five days and 7 of 10 for curcumin by day five—supporting their selection for further study.
The paper remains an early screen using one mouse tumor line, one rat muscle line and an insect model, so any path toward sarcoma treatment still requires mammalian safety work and human-relevant testing.